The Economics of Better Care Follow-Through

Look beyond the total revenue line

Recurring revenue can rise because more patients enroll, prices change or collections improve, even while an earlier cohort’s care follow-through declines. Review cohorts over comparable observation periods to understand which movement is occurring. An aggregate monthly total cannot explain it alone.

Connect the commercial record to care events without confusing them. A paid membership does not prove that required care was completed. A completed visit does not establish that payment was collected. A useful operating view reports both and keeps unpaid balances, refunds and appropriate pauses visible.

Model the opportunity without turning it into a promise

Suppose a hypothetical cohort has 100 patients and 10 fewer unexplained interruptions over a defined period. If each additional completed, paid care step contributes $100 after relevant delivery costs, the scenario is $1,000 in contribution before incremental program costs. The calculation does not establish that those ten outcomes would be caused by a new program.

Use explicit assumptions for eligible volume, completion, collections and costs. Change one assumption at a time to understand sensitivity. Do not substitute total patient lifetime value for revenue actually observed during the evaluation. A scenario can support discovery; it is not a forecast of Synarmic performance.

Find the operational constraint

A clinic may have demand but insufficient appointment availability, unresolved access questions, delayed handoffs or unreliable source data. Sending more outreach will not necessarily remove those constraints. Map the path from a patient’s question to a completed care step and identify where the team can make a concrete change.

A first-90-days engagement program offers a defined structure for onboarding, check-ins and responsive support. It still requires administrative ownership and clinical coverage. The clinic must be able to act on the concerns it surfaces; otherwise, improved detection may simply create a larger queue.

Evaluate contribution and care together

Where feasible, compare usual follow-up with usual follow-up plus the program. Measure completed care, appropriate continuation, patient experience and staff effort before interpreting the economic difference. Include implementation and program costs and explain how staff capacity changes are valued.

Clinical decisions must remain independent of revenue targets. An appropriate treatment pause is not a failure to monetize a patient. The commercial case is strongest when it follows demonstrated, appropriate care and actual collections. It is weakest when every message, booking or predicted retained month is counted as revenue recovered.

Practical review checklist

• Start with incremental care. Count additional clinically appropriate care attributable to the intervention, not every visit completed by participants. A usual-care comparison can help distinguish program effects from care that would have happened anyway.
• Calculate contribution. If a scenario assumes 20 additional visits, $150 collected per visit and $60 in direct visit costs, additional revenue is $3,000 and contribution is $1,800 before program fees and overhead. These are illustrative inputs, not observed Synarmic results.
• Account for timing and work. Rolling 90-day cohorts do not produce all their results in the first calendar month. Allow adequate follow-up and collection time. Include the work generated by replies and clinical handoffs before claiming staff savings or net value.